Profile
Bill Colone is currently the Chief Executive Officer at Singlepass, Inc. He was previously the Chief Executive Officer at UroDev Medical.
Bill Colone active positions
| Companies | Position | Start |
|---|---|---|
Singlepass, Inc.
 Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Chief Executive Officer | - |
Former positions of Bill Colone
| Companies | Position | End |
|---|---|---|
UroDev Medical
 UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
UroDev Medical
UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Health Technology |
Singlepass, Inc.
Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |
- Stock Market
- Insiders
- Bill Colone
